2-(1-(4-ethylphenyl)-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-3-yl)-5-(trifluoromethyl)phenol

ID: ALA5178244

PubChem CID: 168276653

Max Phase: Preclinical

Molecular Formula: C23H18F3N3O2

Molecular Weight: 425.41

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCc1ccc(-n2nc(-c3ccc(C(F)(F)F)cc3O)nc2-c2ccccc2O)cc1

Standard InChI:  InChI=1S/C23H18F3N3O2/c1-2-14-7-10-16(11-8-14)29-22(18-5-3-4-6-19(18)30)27-21(28-29)17-12-9-15(13-20(17)31)23(24,25)26/h3-13,30-31H,2H2,1H3

Standard InChI Key:  ZJAWIJFTHSWPHD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0844   -0.6206    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5829   -0.1357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3280    0.6489    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4969    0.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7518   -0.1357    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9095    1.3635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4971    2.0782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9090    2.7902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7344    2.7902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1463    2.0800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7381    1.3635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3798   -0.3492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5937   -1.1462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3885   -1.3584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9721   -0.7748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7611    0.0186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9658    0.2366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7522    1.0336    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3279    2.0782    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1470    3.5048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9721    3.5048    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1470    4.3315    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.4324    3.9173    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0844   -1.4457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7989   -1.8585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7981   -2.6811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0834   -3.0938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6283   -2.6846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6331   -1.8600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0834   -3.9189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7979   -4.3315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  6  4  1  0
  7  6  2  0
  8  7  1  0
  9  8  2  0
 10  9  1  0
  6 11  1  0
 11 10  2  0
 12  2  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 12 17  1  0
 17 16  2  0
 17 18  1  0
  7 19  1  0
  9 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
 24  1  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 28 27  1  0
 24 29  1  0
 29 28  2  0
 27 30  1  0
 30 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5178244

    ---

Associated Targets(Human)

HaCaT (4069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PC-12 (7051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.41Molecular Weight (Monoisotopic): 425.1351AlogP: 5.59#Rotatable Bonds: 4
Polar Surface Area: 71.17Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.61CX Basic pKa: CX LogP: 6.97CX LogD: 6.76
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.45Np Likeness Score: -1.08

References

1. Lao Y, Wang Y, Chen J, Huang P, Su R, Shi J, Jiang C, Zhang J..  (2022)  Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.,  236  [PMID:35390713] [10.1016/j.ejmech.2022.114315]

Source